Loading…

Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer

The clinicopathological significance of oncofetal mRNA-binding protein, human insulin-like growth factor II mRNA-binding protein 3 (IMP3), in gastric carcinoma (GC) is not fully understood. Tissue microarray blocks with specimens from 346 patients with GC were constructed to evaluate the clinicopath...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2017-01, Vol.37 (1), p.135-142
Main Authors: Lee, Dakeun, Yu, Eun Ji, Ham, In-Hye, Hur, Hoon
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c344t-6ad38695f0d70f4def45c7c1cdc86fbab1711791781918632ee9ab2a3b645a33
cites
container_end_page 142
container_issue 1
container_start_page 135
container_title Anticancer research
container_volume 37
creator Lee, Dakeun
Yu, Eun Ji
Ham, In-Hye
Hur, Hoon
description The clinicopathological significance of oncofetal mRNA-binding protein, human insulin-like growth factor II mRNA-binding protein 3 (IMP3), in gastric carcinoma (GC) is not fully understood. Tissue microarray blocks with specimens from 346 patients with GC were constructed to evaluate the clinicopathological role of IMP3 expression in GC. These results were validated with an online dataset of 876 patients from the Kaplan-Meier Plotter. Sera from 15 controls and 57 patients with GC were collected in order to compare the levels of serum IMP3 between groups. High expression of IMP3 was significantly associated with poor prognosis. Survival curves from the Kaplan-Meier Plotter showed that high IMP3 expression was significantly related to worse disease-free survival and overall survival. Tissue overexpression of IMP3 might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in GCs.
doi_str_mv 10.21873/anticanres.11298
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1852785075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1852785075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-6ad38695f0d70f4def45c7c1cdc86fbab1711791781918632ee9ab2a3b645a33</originalsourceid><addsrcrecordid>eNpFkMtOwzAQRS0EoqXwAWyQl2WRYsdJ7CxL1ZZIBSrUfeQ4TmtI7GC7AsTPkz6A1YxGd45mDgDXGI1CzCi549orwbWVboRxmLIT0Mc0xQGNCToFfRTGKKAIxT1w4dwrQkmSMnIOeiFDGEeM9MH3pFZaCdNyvzG1WXe4GmZNW3eNV0ZDU8FMu22XCmr1JuHcmg-_gTMuvLFBlsHm5Wkc3CtdKr2GS2u8VBoSOMwel-QWTj_b7jq3I3XjOXfeKgEnXAtpL8FZxWsnr451AFaz6WryECye59lkvAgEiSIfJLwkLEnjCpUUVVEpqygWVGBRCpZUBS8wxbuvKcMpZgkJpUx5EXJSJFHMCRmA4QHbWvO-lc7njXJC1jXX0mxdjlkcUhajTtoA4ENUWOOclVXeWtVw-5VjlO-V5__K873ybufmiN8WjSz_Nn4dkx-MEn-T</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1852785075</pqid></control><display><type>article</type><title>Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer</title><source>EZB*</source><creator>Lee, Dakeun ; Yu, Eun Ji ; Ham, In-Hye ; Hur, Hoon</creator><creatorcontrib>Lee, Dakeun ; Yu, Eun Ji ; Ham, In-Hye ; Hur, Hoon</creatorcontrib><description>The clinicopathological significance of oncofetal mRNA-binding protein, human insulin-like growth factor II mRNA-binding protein 3 (IMP3), in gastric carcinoma (GC) is not fully understood. Tissue microarray blocks with specimens from 346 patients with GC were constructed to evaluate the clinicopathological role of IMP3 expression in GC. These results were validated with an online dataset of 876 patients from the Kaplan-Meier Plotter. Sera from 15 controls and 57 patients with GC were collected in order to compare the levels of serum IMP3 between groups. High expression of IMP3 was significantly associated with poor prognosis. Survival curves from the Kaplan-Meier Plotter showed that high IMP3 expression was significantly related to worse disease-free survival and overall survival. Tissue overexpression of IMP3 might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in GCs.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>DOI: 10.21873/anticanres.11298</identifier><identifier>PMID: 28011483</identifier><language>eng</language><publisher>Greece</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor - analysis ; Biomarkers, Tumor - blood ; Case-Control Studies ; Databases, Factual ; Disease-Free Survival ; Enzyme-Linked Immunosorbent Assay ; Female ; Gastrectomy ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Predictive Value of Tests ; Risk Factors ; RNA-Binding Proteins - analysis ; RNA-Binding Proteins - blood ; Stomach Neoplasms - blood ; Stomach Neoplasms - chemistry ; Stomach Neoplasms - mortality ; Stomach Neoplasms - surgery ; Time Factors ; Tissue Array Analysis ; Treatment Outcome ; Up-Regulation ; Young Adult</subject><ispartof>Anticancer research, 2017-01, Vol.37 (1), p.135-142</ispartof><rights>Copyright© 2017 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-6ad38695f0d70f4def45c7c1cdc86fbab1711791781918632ee9ab2a3b645a33</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28011483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Dakeun</creatorcontrib><creatorcontrib>Yu, Eun Ji</creatorcontrib><creatorcontrib>Ham, In-Hye</creatorcontrib><creatorcontrib>Hur, Hoon</creatorcontrib><title>Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>The clinicopathological significance of oncofetal mRNA-binding protein, human insulin-like growth factor II mRNA-binding protein 3 (IMP3), in gastric carcinoma (GC) is not fully understood. Tissue microarray blocks with specimens from 346 patients with GC were constructed to evaluate the clinicopathological role of IMP3 expression in GC. These results were validated with an online dataset of 876 patients from the Kaplan-Meier Plotter. Sera from 15 controls and 57 patients with GC were collected in order to compare the levels of serum IMP3 between groups. High expression of IMP3 was significantly associated with poor prognosis. Survival curves from the Kaplan-Meier Plotter showed that high IMP3 expression was significantly related to worse disease-free survival and overall survival. Tissue overexpression of IMP3 might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in GCs.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biomarkers, Tumor - blood</subject><subject>Case-Control Studies</subject><subject>Databases, Factual</subject><subject>Disease-Free Survival</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Gastrectomy</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Risk Factors</subject><subject>RNA-Binding Proteins - analysis</subject><subject>RNA-Binding Proteins - blood</subject><subject>Stomach Neoplasms - blood</subject><subject>Stomach Neoplasms - chemistry</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - surgery</subject><subject>Time Factors</subject><subject>Tissue Array Analysis</subject><subject>Treatment Outcome</subject><subject>Up-Regulation</subject><subject>Young Adult</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpFkMtOwzAQRS0EoqXwAWyQl2WRYsdJ7CxL1ZZIBSrUfeQ4TmtI7GC7AsTPkz6A1YxGd45mDgDXGI1CzCi549orwbWVboRxmLIT0Mc0xQGNCToFfRTGKKAIxT1w4dwrQkmSMnIOeiFDGEeM9MH3pFZaCdNyvzG1WXe4GmZNW3eNV0ZDU8FMu22XCmr1JuHcmg-_gTMuvLFBlsHm5Wkc3CtdKr2GS2u8VBoSOMwel-QWTj_b7jq3I3XjOXfeKgEnXAtpL8FZxWsnr451AFaz6WryECye59lkvAgEiSIfJLwkLEnjCpUUVVEpqygWVGBRCpZUBS8wxbuvKcMpZgkJpUx5EXJSJFHMCRmA4QHbWvO-lc7njXJC1jXX0mxdjlkcUhajTtoA4ENUWOOclVXeWtVw-5VjlO-V5__K873ybufmiN8WjSz_Nn4dkx-MEn-T</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Lee, Dakeun</creator><creator>Yu, Eun Ji</creator><creator>Ham, In-Hye</creator><creator>Hur, Hoon</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer</title><author>Lee, Dakeun ; Yu, Eun Ji ; Ham, In-Hye ; Hur, Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-6ad38695f0d70f4def45c7c1cdc86fbab1711791781918632ee9ab2a3b645a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biomarkers, Tumor - blood</topic><topic>Case-Control Studies</topic><topic>Databases, Factual</topic><topic>Disease-Free Survival</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Gastrectomy</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Risk Factors</topic><topic>RNA-Binding Proteins - analysis</topic><topic>RNA-Binding Proteins - blood</topic><topic>Stomach Neoplasms - blood</topic><topic>Stomach Neoplasms - chemistry</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - surgery</topic><topic>Time Factors</topic><topic>Tissue Array Analysis</topic><topic>Treatment Outcome</topic><topic>Up-Regulation</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Dakeun</creatorcontrib><creatorcontrib>Yu, Eun Ji</creatorcontrib><creatorcontrib>Ham, In-Hye</creatorcontrib><creatorcontrib>Hur, Hoon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Dakeun</au><au>Yu, Eun Ji</au><au>Ham, In-Hye</au><au>Hur, Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2017-01</date><risdate>2017</risdate><volume>37</volume><issue>1</issue><spage>135</spage><epage>142</epage><pages>135-142</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>The clinicopathological significance of oncofetal mRNA-binding protein, human insulin-like growth factor II mRNA-binding protein 3 (IMP3), in gastric carcinoma (GC) is not fully understood. Tissue microarray blocks with specimens from 346 patients with GC were constructed to evaluate the clinicopathological role of IMP3 expression in GC. These results were validated with an online dataset of 876 patients from the Kaplan-Meier Plotter. Sera from 15 controls and 57 patients with GC were collected in order to compare the levels of serum IMP3 between groups. High expression of IMP3 was significantly associated with poor prognosis. Survival curves from the Kaplan-Meier Plotter showed that high IMP3 expression was significantly related to worse disease-free survival and overall survival. Tissue overexpression of IMP3 might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in GCs.</abstract><cop>Greece</cop><pmid>28011483</pmid><doi>10.21873/anticanres.11298</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2017-01, Vol.37 (1), p.135-142
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_miscellaneous_1852785075
source EZB*
subjects Adult
Aged
Aged, 80 and over
Biomarkers, Tumor - analysis
Biomarkers, Tumor - blood
Case-Control Studies
Databases, Factual
Disease-Free Survival
Enzyme-Linked Immunosorbent Assay
Female
Gastrectomy
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Predictive Value of Tests
Risk Factors
RNA-Binding Proteins - analysis
RNA-Binding Proteins - blood
Stomach Neoplasms - blood
Stomach Neoplasms - chemistry
Stomach Neoplasms - mortality
Stomach Neoplasms - surgery
Time Factors
Tissue Array Analysis
Treatment Outcome
Up-Regulation
Young Adult
title Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathological%20Implication%20of%20Insulin-like%20Growth%20Factor-II%20mRNA-Binding%20Protein%203%20(IMP3)%20Expression%20in%20Gastric%20Cancer&rft.jtitle=Anticancer%20research&rft.au=Lee,%20Dakeun&rft.date=2017-01&rft.volume=37&rft.issue=1&rft.spage=135&rft.epage=142&rft.pages=135-142&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/10.21873/anticanres.11298&rft_dat=%3Cproquest_cross%3E1852785075%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-6ad38695f0d70f4def45c7c1cdc86fbab1711791781918632ee9ab2a3b645a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1852785075&rft_id=info:pmid/28011483&rfr_iscdi=true